COMPANY Data
Movers and SHAKERS

Ticker | TNXP (Nasdaq) |
Current Price | $1.61 ↑ 0.03 |
Market Cap | 30.17M |
Price Target | $10.00 |
Volume | 2.64M |
52wk Range | $1.53 - $36.48 |
ADVANCED MARKET DATA |

Advanced Market Data
Tonix Pharmaceuticals Holding Corp. (TNXP)





Overview
Tonix is a clinical-stage biopharmaceutical company focused on bringing novel therapeutics and diagnostics to prevent and treat infectious diseases, central nervous system disorders and immunology conditions. At Tonix, we are focused on identifying and developing candidates that have the promise to treat and prevent human disease and alleviate suffering. Through our own development, in-licensing, collaborations and acquisitions we are curating an innovative and effective portfolio that targets the relief of pain, and attenuates infection. Currently, our pipeline is primarily comprised of infectious disease, central nervous system (CNS) and immunology product candidates. Our infectious disease portfolio includes COVID-19 next-generation vaccines to prevent COVID-19, an antiviral to treat COVID-19, and a potential treatment for Long COVID. We are progressing small molecules and biologics to treat pain, neurologic, psychiatric and addiction conditions through our CNS portfolio. Finally, our immunology portfolio includes biologics to address immunosuppression, cancer, and autoimmune diseases.
- Industry/Sector Report
- Corporate Presentation
- Corporate Events
- Press Releases/News Feed
- ChannelCAST Videos [1]
- Senior Equity Research Analyst
- Corporate Filings
Tonix Pharmaceuticals Holding Corp. Corporate Filings
Tonix Pharmaceuticals Holding Corp. Corporate Events
Tonix Pharmaceuticals Holding Corp. Press Releases / News Feed
Channelchek
Not available
Channelchek
No reports available